|
|
S Tanaka, J R Wands
J Clin Invest. 1996;
98(9):2100
doi:10.1172/JCI119016
Abstract |
Full text
| PDF

I
nsulin receptor substrate-1 (IRS-1), a substrate of various receptor tyrosine kinases transmits mitogenic signals initiated by extracellular ligands. This protein is involved in normal hepatocyte growth and has been found to be overexpressed in human hepatocellular carcinoma. Expression of a carboxy-terminal truncated IRS-1 molecule containing the pleckstrin homology and phosphotyrosine-binding domains associates with the insulin receptor and prevents tyrosyl phosphorylation of endogenous IRS-1 and Shc proteins. Thus, subsequent activation of downstream signaling molecules induced by insulin and IGF-1 such as phosphatidylinositol-3 kinase and mitogen activated protein kinase is inhibited. The morphologic features of transformed human hepatocellular carcinoma cells change to a differentiated hepatocyte appearance and characteristics of the malignant phenotype as manifested by anchorage independent cell growth and tumor formation in nude mice are lost. These studies demonstrate that signal transduction pathways mediated through or by IRS-1 are important in hepatocyte and human hepatocellular carcinoma cell growth.
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal.
Not all publishers participate in CrossRef, so this information is not comprehensive.
Additionally, data may not reflect the most current citations to this article,
and the data may differ from citation information available from other sources
(for example, Google Scholar, Web of Science, and Scopus).
Total citations by year
in CrossRef
Citations to this article
in CrossRef
(19)
| Title and authors |
Publication |
Year |
Overexpression of insulin receptor substrate-1 and hepatitis Bx genes causes premalignant alterations in the liver
Lisa Longato, Suzanne de la Monte, Noriyoshi Kuzushita, Masayoshi Horimoto, Arlin B. Rogers, Betty L. Slagle, Jack R. Wands
|
Hepatology
|
2009 |
Molecularly targeted therapy for hepatocellular carcinoma
Shinji Tanaka, Shigeki Arii
|
Cancer Science
|
2009 |
Transgenic overexpression of insulin receptor substrate 1 in hepatocytes enhances hepatocellular proliferation in young mice only.
Leonhard Mohr, Kakoli Banerjee, Manuela Kleinschmidt, María Matilde Bartolomé Rodríguez, Jack R Wands
|
Hepatol. Res.
|
2008 |
Synergistic premalignant effects of chronic ethanol exposure and insulin receptor substrate-1 overexpression in liver
Lisa Longato, Suzanne de la Monte, Sophia Califano, Jack R. Wands
|
Hepatology Research
|
2008 |
Aurora kinase B is a predictive factor for the aggressive recurrence of hepatocellular carcinoma after curative hepatectomy
S. Tanaka, S. Arii, M. Yasen, K. Mogushi, N. T. Su, C. Zhao, I. Imoto, Y. Eishi, J. Inazawa, Y. Miki, H. Tanaka
|
Br. J. Surg.
|
2008 |
Molecularly targeted therapy for hepatocellular carcinoma
Shinji Tanaka, Shigeki Arii
|
Kanzo
|
2008 |
Alcohol-Induced Disruption of Endocrine Signaling
Martin J. J. Ronis, Jack R. Wands, Thomas M. Badger, Suzanne M. de la Monte, Charles H. Lang, Jan Calissendorff
|
Alcoholism: Clinical and Experimental Research
|
2007 |
Signal transduction cascades and hepatitis B and C related hepatocellular carcinoma
Mark Branda, Jack R. Wands
|
Hepatology
|
2006 |
Aspartyl-asparagyl β hydroxylase over-expression in human hepatoma is linked to activation of insulin-like growth factor and notch signaling mechanisms
M. Chiara Cantarini, Suzanne M. de la Monte, Maoyin Pang, Ming Tong, Antonia D'Errico, Franco Trevisani, Jack R. Wands
|
Hepatology
|
2006 |
Loss of Raf kinase inhibitor protein promotes cell proliferation and migration of human hepatoma cells.
Han Chu Lee, Bo Tian, John M Sedivy, Jack R Wands, Miran Kim
|
Gastroenterology
|
2006 |
|